
Tacalyx
Developer of therapeutics designed to target cancer-specific carbohydrate antigens. The company's therapeutics combine the ability to synthesize sufficient amounts of complex structures with analysis ...
Valuation
$0
Share Price
N/A
Total Raised
$23.1M
Last Round
N/A